81 related articles for article (PubMed ID: 23727426)
1. Update on the Use of l-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic Leukemia.
Andrade AF; Borges KS; Silveira VS
Clin Med Insights Oncol; 2014; 8():95-100. PubMed ID: 25210485
[TBL] [Abstract][Full Text] [Related]
2. Correlation of ex vivo and in vivo ammonia production with L-asparaginase biological activity in adults with lymphoid malignancies.
Nakamura T; Oya S; Ozawa H; Maehiro Y; Muta S; Umeda M; Takaki Y; Fukuyama T; Yamasaki Y; Yamaguchi M; Aoyama K; Mouri F; Naito Y; Nagafuji K
Int J Hematol; 2024 Apr; 119(4):426-431. PubMed ID: 38363480
[TBL] [Abstract][Full Text] [Related]
3. Determination of l-Asparaginase Activity and Its Therapeutic Monitoring in Children with Hematological Malignancies in a Single Croatian Center.
Lenicek Krleza J; Katusic Bojanac A; Jakovljevic G
Diagnostics (Basel); 2024 Mar; 14(6):. PubMed ID: 38535043
[TBL] [Abstract][Full Text] [Related]
4. Desirable L-asparaginases for treating cancer and current research trends.
Tsegaye K; Tsehai BA; Getie B
Front Microbiol; 2024; 15():1269282. PubMed ID: 38591038
[TBL] [Abstract][Full Text] [Related]
5. Comment on: Desensitization using PEGasparaginase in the era of commercially available Erwinia: A single-institution report on efficacy, cost, and resource utilization.
Tong WH
Pediatr Blood Cancer; 2024 May; 71(5):e30935. PubMed ID: 38433328
[No Abstract] [Full Text] [Related]
6. Extracellular L-Asparaginase Synthesis
Wahab MRA; Palaniyandi T; Wyson J; Sivaji A; Thamada S
Avicenna J Med Biotechnol; 2024; 16(1):40-48. PubMed ID: 38605737
[TBL] [Abstract][Full Text] [Related]
7. L-asparaginase and PEG asparaginase--past, present, and future.
Keating MJ; Holmes R; Lerner S; Ho DH
Leuk Lymphoma; 1993; 10 Suppl():153-7. PubMed ID: 8481665
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcomes of children with acute lymphoblastic leukemia in a middle-income developing country: high mortalities, early relapses, and poor survival.
Abdelmabood S; Fouda AE; Boujettif F; Mansour A
J Pediatr (Rio J); 2020; 96(1):108-116. PubMed ID: 30240631
[TBL] [Abstract][Full Text] [Related]
9. Acute lymphoblastic leukemia in children with Down syndrome: Comparative analysis versus patients without Down syndrome.
Pennella CL; Rossi JG; Baialardo EM; Alonso CN; Guitter MR; Sánchez La Rosa CG; Millán NC; Alfaro EM; Zubizarreta PA; Felice MS
Arch Argent Pediatr; 2018 Aug; 116(4):e500-e507. PubMed ID: 30016023
[TBL] [Abstract][Full Text] [Related]
10. [Epigenetic alterations in acute lymphoblastic leukemia].
Navarrete-Meneses MDP; Pérez-Vera P
Bol Med Hosp Infant Mex; 2017; 74(4):243-264. PubMed ID: 29382514
[TBL] [Abstract][Full Text] [Related]
11. [Humoral immune response induced by influenza vaccine in children with acute lymphoblastic leukemia].
Cerda C; Martínez-Valdebenito C; Barriga F; Contreras M; Vidal M; Moreno R; Claverie X; Contreras P; Huenuman L; García T; Rathnasighe R; Medina R; Ferrés M; Le Corre N
Rev Chilena Infectol; 2020 Apr; 37(2):138-146. PubMed ID: 32730479
[TBL] [Abstract][Full Text] [Related]
12. [Oral diseases in children with acute lymphoblastic leukemia with chemotherapy treatment].
Juárez-López MLA; Solano-Silva MN; Fragoso-Ríos R; Murrieta-Pruneda F
Rev Med Inst Mex Seguro Soc; 2018; 56(2):132-135. PubMed ID: 29901909
[TBL] [Abstract][Full Text] [Related]
13. Penicillium and Talaromyces endophytes from Tillandsia catimbauensis, a bromeliad endemic in the Brazilian tropical dry forest, and their potential for L-asparaginase production.
Silva LF; Freire KTLS; Araújo-Magalhães GR; Agamez-Montalvo GS; Sousa MA; Costa-Silva TA; Paiva LM; Pessoa-Junior A; Bezerra JDP; Souza-Motta CM
World J Microbiol Biotechnol; 2018 Oct; 34(11):162. PubMed ID: 30368630
[TBL] [Abstract][Full Text] [Related]
14. PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic lymphoma.
Zheng W; Ren H; Ke X; Xue M; Zhang Y; Xie Y; Lin N; Tu M; Liu W; Ping L; Ying Z; Zhang C; Deng L; Wang X; Song Y; Zhu J
Chin J Cancer Res; 2017 Feb; 29(1):66-74. PubMed ID: 28373755
[TBL] [Abstract][Full Text] [Related]
15. [Update on L-asparaginase treatment in paediatrics].
Moscardó Guilleme C; Fernández Delgado R; Sevilla Navarro J; Astigarraga Aguirre I; Rives Solà S; Sánchez de Toledo Codina J; Fuster Soler JL; Parra Ramirez L; Molina Garicaño J; González Martínez B; Madero López L
An Pediatr (Barc); 2013 Nov; 79(5):329.e1-329.e11. PubMed ID: 23727426
[TBL] [Abstract][Full Text] [Related]
16. Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL).
Kwok CS; Kham SK; Ariffin H; Lin HP; Quah TC; Yeoh AE
Pediatr Blood Cancer; 2006 Sep; 47(3):299-304. PubMed ID: 16302217
[TBL] [Abstract][Full Text] [Related]
17. Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial.
Plourde PV; Jeha S; Hijiya N; Keller FG; Silverman LB; Rheingold SR; Dreyer ZE; Dahl GV; Mercedes T; Lai C; Corn T
Pediatr Blood Cancer; 2014 Jul; 61(7):1232-8. PubMed ID: 24436152
[TBL] [Abstract][Full Text] [Related]
18. Asparaginase revisited.
van den Berg H
Leuk Lymphoma; 2011 Feb; 52(2):168-78. PubMed ID: 21281233
[TBL] [Abstract][Full Text] [Related]
19. Erwinia asparaginase in pediatric acute lymphoblastic leukemia.
Salzer W; Seibel N; Smith M
Expert Opin Biol Ther; 2012 Oct; 12(10):1407-14. PubMed ID: 22946493
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
